CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in SRPT — Sarepta Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in SRPT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$17,214,967
+$743,925 QoQ
Shares Held
791,129
+3.4% QoQ
Ownership
0.749%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.98205096766772.ToString("F0")%
Shared 0.ToString("F0")%
None 0.01794903233227451.ToString("F0")%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. SRPT ranks #69 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in SRPT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,214,967 | 791,129 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $16,471,042 | 765,383 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $11,738,339 | 609,151 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $11,523,296 | 673,877 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $41,246,291 | 646,291 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $75,841,640 | 623,749 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $76,401,332 | 611,749 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $95,551,606 | 604,757 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $76,308,772 | 589,439 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $55,583,409 | 576,412 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $67,925,748 | 560,351 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $63,448,889 | 554,042 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $71,666,638 | 519,964 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $66,922,757 | 516,459 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $54,677,505 | 494,640 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $36,554,543 | 487,654 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $37,441,744 | 479,285 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $42,168,523 | 468,279 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $38,717,584 | 418,659 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $31,390,867 | 403,793 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $29,397,016 | 394,432 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $66,567,650 | 390,449 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $53,993,509 | 384,487 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $57,751,100 | 360,179 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $33,063,257 | 338,001 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||